Effectiveness and Cost-effectiveness of a Pre-emptive Genotyping Strategy in Patients Receiving Tacrolimus

NCT06701825 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

114

Enrollment

OTHER

Sponsor class

Conditions

Kidney Disease, Chronic
Transplant Recipient (Kidney)
Immunosuppression

Interventions

DRUG: Tacrolimus
DRUG: Tacrolimus

Sponsor

Instituto de Investigación Hospital Universitario La Paz

Collaborators

[object Object]